Navigation Links
Quintiles Signs Agreement to Acquire Eidetics
Date:5/7/2008

Proposed acquisition to augment Quintiles Consulting offerings

RESEARCH TRIANGLE PARK, N.C., May 7 /PRNewswire/ -- Quintiles Transnational Corp. today announced that it has signed an agreement to acquire Eidetics, a privately held decision-analytics and market research consulting firm located in Boston as part of its expanding Quintiles Consulting business.

The acquisition of Eidetics will strengthen Quintiles' core consulting offerings in the areas of product development, commercialization and market access. Quintiles is expanding its consulting practices to help its pharmaceutical, biotech and medical device clients navigate the complex business environment.

"The addition of Eidetics to our Quintiles Consulting business will further strengthen our ability to provide our clients with distinctive, data-driven, strategic solutions to their toughest challenges throughout the product lifecycle," said Jay Norman, President, Quintiles Consulting.

Eidetics has provided research-based market insights and data analytics to support business decision making in drug development and commercialization for the past 20 years and counts among its repeat clients 18 of the top 20 pharmaceutical companies.

"We are looking forward to welcoming the Eidetics team to Quintiles Consulting," Norman said. "They have earned an enviable reputation for strong research and analytics expertise and outstanding client service. Together, we will offer industry-leading strategic consulting, powered by life sciences expertise, operational insights and data analytics."

"We are excited about the opportunity to become part of the Quintiles organization," said Jim Kirk, Partner, Eidetics. "We believe that joining Quintiles Consulting will build upon the past success of Eidetics' business, while providing our clients enhanced clinical, patient and provider data, greater therapeutic depth and access to global resources."

The transaction is contingen
'/>"/>

SOURCE Quintiles Transnational Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Quintiles Consulting Business Expands
2. Quintiles Completes Previously Announced New Investor Partnership, Co-Led by Founder, Chairman and CEO Dennis Gillings, Bain Capital, TPG and 3i
3. Quintiles to Open Clinical Research Office in Wilmington, NC
4. Quintiles Central Lab, Clinical Development in China to Expand, Relocate to New Facility
5. Quintiles Names Kelly McKee Executive Director of Operations for Public Health and Government Services Unit
6. Expert Cardiologist Joins Quintiles Medical Group
7. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
8. ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase
9. Assay Designs(TM) Announces Collaboration with Medical University of South Carolina (MUSC)
10. Botaneco signs feasibility agreement with Croda to develop specialty crop oil formulation
11. DelSite Signs Technology Evaluation Agreement With Global Pharmaceutical Company for GelSite(R) Polymer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... 24, 2014 DuPont Pioneer and ... more than double the acreage contracted for Plenish® ... its soybean crush facility in Salisbury, Md. The ... will target several markets including foodservice and food ... performance. , For the 2015 growing season, Perdue ...
(Date:10/25/2014)... A new way to produce engineered ... current skin grafting technologies, it also speeds up the ... outlined in the October issue of STEM CELLS Translational ... injuries that result from severe burns and chronic wounds. ... regenerative elements. These wounds heal by contraction, with epithelization ...
(Date:10/25/2014)... Investor-Edge has initiated coverage on ... ), Vertex Pharmaceuticals Inc. (NASDAQ: VRTX ), ... Pharmaceuticals Inc. (NASDAQ: PPHM ), and StemCells ... can be accessed at: http://investor-edge.com/register . ... on a positive note as the Dow Jones Industrial ...
(Date:10/22/2014)... and BOSTON , Oct. 22, ... a leading global specialty pharmaceutical company, and Rhythm, a ... an exclusive option to acquire Rhythm,s wholly owned subsidiary, ... peptide ghrelin agonist, for the treatment of diabetic gastroparesis ... has completed a successful Phase 2 trial of relamorelin ...
Breaking Biology Technology:DuPont Pioneer, Perdue AgriBusiness Announce Plans to Double Acreage for the 2015 Plenish® High Oleic Soybean Program 2DuPont Pioneer, Perdue AgriBusiness Announce Plans to Double Acreage for the 2015 Plenish® High Oleic Soybean Program 3DuPont Pioneer, Perdue AgriBusiness Announce Plans to Double Acreage for the 2015 Plenish® High Oleic Soybean Program 4New engineering method shows promise for faster healing, more cosmetically appealing skin grafts 2New engineering method shows promise for faster healing, more cosmetically appealing skin grafts 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 2Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 4Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 5Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5
... dollars, QUEBEC CITY, Nov. 12 /PRNewswire-FirstCall/ - ... a global biopharmaceutical company focused on,endocrine therapy and ... agreement to sell to Cowen Healthcare Royalty Partners, ... of Cetrotide(R) covered by,its license agreement with Merck ...
... Pasteur and Chumakov Institute Russian Academy Medical Sciences, ... ... National "Project Health", PARIS, November 12 ... Russia has,chosen inactivated polio vaccine (IPV) from Sanofi Pasteur for ...
... Standard & Poor,s will make the,following changes to the S&P 500 and S&P ... GGP) will be removed from the S&P 500 ... today,s close of trading General Growth Properties had a ... in the index., -- S&P MidCap 400 constituent Cephalon Inc. ...
Cached Biology Technology:AEterna Zentaris Agrees to Sell Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners 2AEterna Zentaris Agrees to Sell Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners 3AEterna Zentaris Agrees to Sell Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners 4Russia Chooses Inactivated Polio Vaccine from Sanofi Pasteur for Primary Immunization of all Infants 2Russia Chooses Inactivated Polio Vaccine from Sanofi Pasteur for Primary Immunization of all Infants 3Russia Chooses Inactivated Polio Vaccine from Sanofi Pasteur for Primary Immunization of all Infants 4Russia Chooses Inactivated Polio Vaccine from Sanofi Pasteur for Primary Immunization of all Infants 5Russia Chooses Inactivated Polio Vaccine from Sanofi Pasteur for Primary Immunization of all Infants 6Standard & Poor's Announces Changes to U.S. Indices 2Standard & Poor's Announces Changes to U.S. Indices 3
(Date:10/16/2014)... challenged conventional thinking on how the bowel lining develops ... how bowel cancer starts. , The researchers produced evidence ... the ,crypts, that are a feature of the bowel ... bowel cancer development, a controversial finding as scientists are ... 3D imaging technologies, Dr Chin Wee Tan and Professor ...
(Date:10/15/2014)... 2014 Sandata Technologies, LLC, an industry ... care, today announced it released a case study ... Visit Verification™ Solution (EVV™)  for Quality Care Services, ... company founded in 1996 and has five locations ... The study details the challenges facing Quality ...
(Date:10/15/2014)... pneumonia in female mice to an enzyme activated by ... more resistant to respiratory infections than males. Now, an ... to bacterial pneumonia in female mice is linked to ... show that this enzyme is ultimately activated by the ... team, lead by Professor Lester Kobzik at the Harvard ...
Breaking Biology News(10 mins):Cryptic clues drive new theory of bowel cancer development 2Sandata Announces Case Study with Quality Care Services, Inc. 2
... University of Alberta researchers discover that animals zig when ... told them. , In studying the spatial memory of ... to discover the birds contradicting prior research that showed ... reveal a different pattern. Previously, only animals that had ...
... study suggests that a suspect gene may increase susceptibility ... processing negative emotion. People with the depression-linked gene variant ... mood-regulating circuit. How well the circuit was connected accounted ... at the National Institute of Health's (NIH) National Institute ...
... billion neurons, and each has hundreds of connections with ... essential to understanding brain function, and the task is ... approach to mapping neuron connectivity published in PLoS Computational ... of Neuroscience at the University of Minnesota, the task ...
Cached Biology News:Chickadees can help humans get their bearings 2Depression gene may weaken mood-regulating circuit 2Depression gene may weaken mood-regulating circuit 3